• (-)-JQ1 as a BET Inhibitor Negative Control

  2026-08-17

  (-)-JQ1 is an inactive JQ1 stereoisomer designed to separate BRD4-dependent biology from solvent, scaffold, and off-target effects. This article explains how to deploy it in AML, epigenetics research, transcriptional assays, and mechanistic control experiments.

• Annexin V-FITC/PI Apoptosis Assay Kit Guide

  2026-08-17

  The Annexin V-FITC/PI Apoptosis Assay Kit is more than a viability readout: it maps membrane-state transitions during cell death. This guide connects phosphatidylserine externalization to the hypoxia-activated BNNC study and shows how to design interpretable, orthogonally validated apoptosis experiments.

• Ademetionine in Neurological Disorders: Evidence Review

  2026-08-16

  The 1994 review by Bottiglieri, Hyland, and Reynolds connects ademetionine (S-adenosylmethionine; SAMe) biology with neurological and psychiatric disease, emphasizing methyl transfer, monoamine metabolism, and folate–vitamin B12 interactions. Its main practical contribution is a mechanism-led framework for interpreting antidepressant, cognitive, remyelination, and metabolic observations while recognizing that much of the clinical evidence remained preliminary.

• Spermine Tetrahydrochloride in Polyphosphazenes

  2026-08-15

  Andrianov and colleagues showed that spermine-cross-linked ionic polyphosphazenes can assemble with lysozyme into soluble or nanoparticulate protein formulations while largely preserving activity against a small-molecule substrate. The study also demonstrates that particle architecture, cross-linking, and PEG grafting influence how an encapsulated protein is presented to bacterial cells, providing a useful framework for analyzing polymer–protein interactions.

• Trichostatin A (TSA): Practical Protocol Guide

  2026-08-14

  Trichostatin A (TSA), SKU A8183, provides a reversible HDAC-inhibition tool for studying histone acetylation, cell-cycle responses, differentiation, and cancer-related phenotypes. It is water-insoluble, requires controlled organic-solvent preparation, and should be used as a short-term research reagent rather than a clinical or universally transferable treatment condition.

• Benzyl-Activated Streptavidin Magnetic Beads for RNA Assays

  2026-08-14

  Benzyl-activated Streptavidin Magnetic Beads can support rigorous RNA–protein capture workflows inspired by SNORA38B research. This article connects bead chemistry, assay controls, and mechanistic validation without overstating what a capture reagent can prove.

• Pseudo-UTP for Advanced mRNA Workflows

  2026-08-13

  Build more durable, translationally efficient RNA with Pseudo-UTP while preserving a disciplined IVT and quality-control workflow. This guide connects pseudouridine-modified mRNA synthesis to vaccine, gene therapy, and oncology assay design, with practical controls and troubleshooting steps.

• Radix Rehmanniae Praeparata Restores Lipid Balance in HIRI

  2026-08-13

  This study identifies lipid-metabolism restoration as a central mechanism by which Radix Rehmanniae Praeparata extracts reduce hepatic ischemia-reperfusion injury. Its evidence connects AMPK activation with suppression of the SCAP-SREBP2 cholesterol-synthesis pathway and enhancement of LXRα-dependent cholesterol efflux, offering a mechanistic framework for hepatocyte lipid-injury models.

• Bsa I (RNase-free): Practical Workflow Guide

  2026-08-12

  Bsa I (RNase-free) supports sequence-directed DNA cleavage in gene cloning, DNA manipulation, and RNA-sensitive molecular biology research. This guide explains how to plan, set up, and quality-control workflows while staying within the product dossier; it is for scientific research only, not diagnostic, clinical, or medical use.

• XAV-939 Workflows for Wnt Pathway Reprogramming

  2026-08-12

  XAV-939 enables controlled tankyrase inhibition for Wnt/β-catenin pathway studies, from human cardiac fibroblast reprogramming to cancer, fibrosis, and bone biology. This practical guide connects the reference study’s high-throughput workflow with dosage planning, assay selection, and troubleshooting strategies.

• Salvianolic Acid B Targets LH2 in Pulmonary Fibrosis

  2026-08-11

  The reference study identifies lysyl hydroxylase 2 (LH2/PLOD2)-associated collagen cross-linking as a tractable mechanism in pulmonary fibrosis and shows that Salvianolic acid B suppresses this pathway. Its combined cellular, transcriptomic, and tissue-level evidence supports further evaluation of Dan Shen Suan B as a mechanistically defined antifibrotic research compound, while leaving questions about direct target engagement, dosing, and clinical translation unresolved.

• IEM-1925 in Soman-Induced Status Epilepticus

  2026-08-11

  The 2026 NeuroToxicology study shows that IEM-1925, a dual AMPA/NMDA glutamate receptor antagonist, produced antiseizure, neuroprotective, and cognitive benefits in a rat model of soman-induced status epilepticus. Its multimodal design provides a useful framework for connecting EEG seizure control with neuropathology and behavioral recovery, while also clarifying why the findings should not be generalized directly to other receptor-selective compounds.

• PX-478 2HCl: From Hypoxia Biology to Translation

  2026-08-10

  PX-478 2HCl offers translational researchers a pharmacologic way to interrogate HIF-1α across tumor hypoxia, radiation response, ischemic tumor biology, and prenatal hypoxia models. This thought-leadership analysis connects mechanism, assay design, model selection, evidence boundaries, and research strategy beyond conventional product specifications.

• (S)-(+)-Methoprene: From JH Biology to Translation

  2026-08-09

  A mechanistic and translational framework for using (S)-(+)-Methoprene to connect juvenile hormone biosynthesis, Met-dependent transcription, insect development, and endocrine disruption research.

• NMDA–Cav2.1 Control of PV Interneuron Maturation

  2026-08-08

  Singh et al. show that developmental NMDAR signaling in prospective parvalbumin interneurons is required for the maturation of Cav2.1-dependent GABA release. Using cell-type-specific genetics, paired patch-clamp recordings, calcium-channel pharmacology, and rescue experiments, the study links early NMDAR dysfunction to impaired cortical inhibition relevant to schizophrenia biology.

14823 records 1/989 page Next 12345 下5页 Last page